Burks J., Reed, R. E., and Desai S. D. ISGylation governs the oncogenic
function of Ki-Ras in breast cancer
. (2014) Oncogene, 33:794-803 [PMID:23318454]

 Desai S. D., Reed R. E., Babu, S., and Lorio, E. ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells. (2013) 288:2388-2402, [PMCID: PMC3554909]

D’Souza A. J., Desai S. D., Rudner X., Kelly, M. N., Ruan, S., Shellitto, J. E. Suppression of the Macrophage Proteasome by Ethanol Impairs MHC Class I Antigen Processing and Presentation. (2013) PLoS ONE, 8:e56890

Desai S. D. , Reed, R. E., Burks, J., Wood, L. M., Pullikuth, A. K., Haas, A. L., Liu, L. F., Breslin, J. W., Meiners, S., and Sankar, S. ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. (2012) J. Exper. Biol. Med. 237:38-49 [(Highlighted as Feature Article, J. Exper. Biol. Med; Perspective article, Expert Rev. Proteomics 9, 7 (2012). Report also carried by many national and international news services and local television (WGNO-ABC 26 and F0X8)]. [PMID: 22185919]; [PMCID is in process]

Klionsky et al. Guidelines for the use and interpretation of assays for monitoring autophagy. (2012) Autophagy 8:445-544 [PMCID: PMC3404883]

Wood, L. M., Sankar, S., Reed, R. E., Haas, A. L., Liu, L. F., McKinnon, P., andDesai, S. D. A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway. (2011) PLoS ONE6:e16422  [PMCID: PMC3027683]

Desai, S. D. , Wood, L. J., Tsai, Y. C., Hsieh, T. S., Marks, J. R., Scott, G. L., Giovanella, B. C., and Liu, L. F. ISG15 as a novel tumor biomarker for drug sensitivity.  (2008) Mol. Cancer Ther. 7:1430-1439 [PMCID: PMC2561335]

Desai, S. D., Haas, A. L., Wood, L. M., Tsai, Y, C., Pestka, S., Rubin, E. H., Saleem, A., Kamal, A. N., and Liu, L. F. Elevated expression of ISG15 in tumor cells inhibits protein degradation by 26S Proteasome. (2006) Cancer Res. 66:921-928 [PMID: 16424026]      

Desai, S. D. , Zhang, H., Rodriguez-Bauman, A., Yang, J. M., Wu, X., Gounder, M., Rubin, E., and Liu, L. F. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. (2003)  Mol. Cell. Biol.23: 2341-2350 (2003) [PMID: 12640119]

Xiao, H., Mao, Y., Desai, S. D., Zhou, N., Ting, C. Y., Hwang, J., and Liu, L. F. The topoisomerase IIb circular clamp arrests transcription and signals a 26S proteasome pathway.  Proc. Natl. Acad. Sci. (2003) 100:3239-3244 [PMCID: PMC152276]

Mao, Y., Desai, S. D., Ting, C. Y., Hwang, J., and Liu, L. F. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. (2001) J. Biol. Chem.276:40652-40658  [PMID: 11546768]

Desai, S. D. , Li, T. K., Rodriguez-Bauman, A., Rubin, E. H., and Liu, L. F. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. (2001)Cancer Res. 61:5926-5932 (2001) [PMID: 11479235]

Mao, Y., Desai, S. D., and Liu, L. F. SUMO-1 conjugation to human DNA topoisomerase II isozymes. (2000) J. Biol. Chem.275:26066-26073 [PMID: 10862613]

Mao, Y., Sun, M., Desai, S. D., and Liu, L. F. SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. (2000) Proc. Natl. Acad. Sci. U.S.A. 97:4046-4051 [PMCID: PMC18143]

Desai, S. D. , Liu, L. F., Vazquez-Abad, D., and D'Arpa, P. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin. (1997) J. Biol. Chem.272:24159-24164 [PMID: 9305865]

Book chapter

Desai S. D. Ubiquitin and ubiquitin-like proteins in topoisomerase-mediated DNA damage, In DNA Topoisomerases and Cancer, Yves Pommier Ed. Springer press, New York, p355-379, 2012

To search for all of Dr. Desai's publications click here.